Mistras remains a 'Buy' as margin expansion, revenue diversification, and O&G recovery drive a compelling upside case. MG's ...
MG has revealed the elder sibling of the Gloster in India, going by the name Majestor. The SUV was first showcased in 2025 at the Bharat Mobility Expo and had been awaited by fans ever since. Its ...
This is branded content for Compudose - Elanco IMPLANTS have been used to improve growth rates and feed conversion efficiency ...
Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today provided business ...
Everyday Health on MSN
Top supplements for women: 7 to consider for better health
Learn about the essential nutrients women need in every stage of life, including prenatal vitamins, supplements for menopause, and nutrients for women over 50.
Initiation of confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia is planned for Q2 2026, with topline data anticipated in 2H 2027BURLINGTON, Mass., March 11, 2026 (GLO ...
Exploration Potential Remains: The ore body of the Borborema deposit remains open along strike and down dip. Aura believes the project will benefit from additional drilling both to extend the Mineral ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 10:30 AM ESTCompany ParticipantsWilliam Meury - CEO, President ...
AZoCleantech on MSN
Engineered carbon nitride catalyst produces solar hydrogen directly from seawater
The study demonstrates a breakthrough in hydrogen production from seawater using carbon nitride, highlighting its potential ...
Detailed price information for Arcturus Therapeutics Ltd (ARCT-Q) from The Globe and Mail including charting and trades.
This study presents valuable findings implicating nuclear export in the regulation of protein condensate behaviour and TDP-43 phase behaviour, suggesting a link to pathogenic aggregation in ALS/FTD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results